T-G. Truong

机构：Cleveland Clinic

发表论文 4 篇 · 总被引 79 次 · h-index 3

代表论文

• LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801) (2022 · Annals of Oncology · 被引 56)
• LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801 (2023 · Annals of Oncology · 被引 18)
• 1601O 3-year survival with neoadjuvant-adjuvant pembrolizumab from SWOG S1801 (2025 · Annals of Oncology · 被引 5)
• 1118P Real-world treatment patterns and outcomes among patients with BRAF+ metastatic melanoma refractory to first-line immunotherapy (2023 · Annals of Oncology)